---
title: "LifeSci Capital Sticks to Their Buy Rating for Liquidia Technologies (LQDA)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293825271.md"
description: "LifeSci Capital analyst Gaurav Maini maintained a Buy rating on Liquidia Technologies (LQDA) with a $101.00 price target. Maini, who has a 93.75% success rate, covers the Healthcare sector. The stock currently holds a Strong Buy consensus among analysts with an average price target of $87.29."
datetime: "2026-07-25T14:45:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293825271.md)
  - [en](https://longbridge.com/en/news/293825271.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293825271.md)
generator: "portal-rs"
---

# LifeSci Capital Sticks to Their Buy Rating for Liquidia Technologies (LQDA)

In a report released today, Gaurav Maini from LifeSci Capital maintained a Buy rating on Liquidia Technologies, with a price target of $101.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Maini covers the Healthcare sector, focusing on stocks such as Tenax Therapeutics, Tectonic Therapeutic, and Liquidia Technologies. According to TipRanks, Maini has an average return of 28.6% and a 93.75% success rate on recommended stocks. 

Liquidia Technologies has an analyst consensus of Strong Buy, with a price target consensus of $87.29.

### Related Stocks

- [LQDA.US](https://longbridge.com/en/quote/LQDA.US.md)
- [TENX.US](https://longbridge.com/en/quote/TENX.US.md)
- [TECX.US](https://longbridge.com/en/quote/TECX.US.md)

## Related News & Research

- [Alpha Buying: 4 Biotech Stocks a Healthcare Specialist Is Buying](https://longbridge.com/en/news/297940670.md)
- [Liquidia Corporation $LQDA Shares Sold by Pale Fire Capital SE](https://longbridge.com/en/news/297896782.md)
- [Will FDA Fast Track for YUTREPIA in Raynaud’s Phenomenon Reshape Liquidia’s (LQDA) Narrative](https://longbridge.com/en/news/298038188.md)
- [Liquidia executives to speak at Wells Fargo annual healthcare conference fireside chat](https://longbridge.com/en/news/297652928.md)
- [TD Cowen Keeps Their Buy Rating on Amgen (AMGN)](https://longbridge.com/en/news/298357051.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**